Nothing said here yet.
to join the conversation.
| Quinn William P.President, CEO and CFO | Sell | 9,132 | $29.6K | Fri, Sep 18 |
| Yonehiro GrantChief Operating Officer | Sell | 6,850 | $22.2K | Fri, Sep 18 |
| Nemec SarahSenior VP, Finance and PAO | Sell | 4,077 | $13.2K | Fri, Sep 18 |
| Quinn William P.President, CEO and CFO | Sell | 6,545 | $21.7K | Thu, Sep 17 |
| Yonehiro GrantChief Operating Officer | Sell | 4,909 | $16.3K | Thu, Sep 17 |
| Nemec SarahSenior VP, Finance and PAO | Sell | 2,922 | $9.7K | Thu, Sep 17 |
| Quinn William P.President, CEO and CFO | Sell | 1,889 | $7.1K | Wed, Sep 16 |
| Yonehiro GrantChief Operating Officer | Sell | 1,417 | $5.3K | Wed, Sep 16 |
| Nemec SarahSenior VP, Finance and PAO | Sell | 843 | $3.2K | Wed, Sep 16 |
| Quinn William P.President, CEO and CFO | Buy | 637 | $2.5K | Fri, Jun 5 |
| Nemec SarahSenior VP, Finance and PAO | Buy | 509 | $2.0K | Fri, Jun 5 |
The leading multi-sport brand introduces a new Camo Glove Series, followed by sitewide holiday savings and a week-long member-exclusive event. AUSTIN, Texas, Oct.
Launching October 12th, the brand that transformed the batting glove market brings its performance-driven design to football with an innovative skill glove and the first-ever SFIA-approved tackified arm sleeve, engineered to work together as one connected grip system.
Independent, employee-driven recognition affirms the people-first culture fueling BOLT ON's next wave of innovation in automotive repair technology TAMPA, Fla., Aug.
The collaborative glove will debut and be available for purchase at the Texas Rangers game on August 23, and afterward at BRUCEBOLT.us, with 10% of proceeds benefiting The Burger Family Foundation AUSTIN, Texas, Aug.
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -53.87% and -99.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected to be released with Bolt's 3Q 2026 resultsCash balance of $18.1 million as of June 30, 2026 anticipated to fund operations into 1Q 2027 REDWOOD CITY, Calif., Aug.
VANCOUVER, BC / ACCESS Newswire / June 12, 2026 /Bolt Metals Corp. ("Bolt" or the "Company") (CSE:BOLT)(OTCQB:PCRCF)(FSE:A3D8AK), is pleased to announce that, further to its press releases dated May 13, 2026, the letter of intent dated October 23, ...
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -51.23% and -98.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected in 3Q 2026 Cash balance of $23.9 million as of March 31, 2026 anticipated to fund operations into 2027, including completion of the dose…
VANCOUVER, BC / ACCESS Newswire / April 9, 2026 /Bolt Metals Corp. ("Bolt" or the "Company") (TSXV:BOLT)(OTCQB:PCRCF)(FSE:A3D8AK), a North American mineral acquisition and exploration company, is pleased to announce the appointment of Mr. Rick Mah ...
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +10.70% and +150.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?